ArticleHeliyon2023
A noncontact modular infectious disease screening clinic aiming to achieve zero cross-contaminations.
Article in Heliyon, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed, 1 citations in OpenAlex.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Screening clinics play a major role in preventing the transmission of infectious diseases. The main problem that should be addressed is the exposure to cross-infection between healthcare workers and individuals intended to be tested. In this study, a noncontact modular screening clinic (NCMSC) was developed that addresses the problems of existing screening clinics and the risks of cross-contamination during the infectious disease sampling process. The space and ventilation system of the NCMSC were designed to effectively remove viral aerosols to avoid cross-contamination. The spatial configurations that enabled noncontact specimen sampling and pressure differential control was achieved. Regarding the measurement method with the use of tracer gas, an experimental field test framework and procedure that can evaluate the cross-contamination between rooms were presented. It is the observation of pollutants (tracer gas) in two different modes (normal breathing and AGP from a patient) in a screening clinic with ventilation, compared to the room next door, where the HCW is located. Additionally, based on onsite experiments using SF
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.